-
公开(公告)号:US20070184112A1
公开(公告)日:2007-08-09
申请号:US11684821
申请日:2007-03-12
申请人: Patrick Wong , Francisco Jao , David Edgren , Robert Skluzacek , Shu Li
发明人: Patrick Wong , Francisco Jao , David Edgren , Robert Skluzacek , Shu Li
IPC分类号: A61K9/24
CPC分类号: A61K9/0004
摘要: A dosage form that facilitates the controlled release of an active agent at a desired release rate or release rate profile includes a bi-layer membrane system and an osmotic core. The bi-layer membrane system includes a semipermeable membrane and an osmosensitive membrane and forms an internal compartment occupied by the osmotic core. The osmotic core includes an active agent composition and a light push layer. A passageway is formed through the bi-layer membrane system and permits expulsion of the active agent composition from the dosage form during operation. The bi-layer membrane system and the osmotic core are formulated and formed to provide controlled release of the active agent included in the active agent composition, while simultaneously facilitating increased loading of active agent within a dosage form of given dimension and increasing the delivery efficiency of such active agent relative to prior osmotic dosage forms including a push layer.
摘要翻译: 有利于以期望的释放速率或释放速率曲线控制释放活性剂的剂型包括双层膜系统和渗透核。 双层膜系统包括半透膜和渗透膜,并形成由渗透芯占据的内部隔室。 渗透芯包括活性剂组合物和轻推层。 通过双层膜系统形成通道,并允许活性剂组合物在操作期间从剂型中排出。 双层膜系统和渗透芯被配制和形成以提供包含在活性剂组合物中的活性剂的受控释放,同时促进活性剂在给定维度的剂型中的负载增加,并且提高 这种活性剂相对于包括推层的先前的渗透剂型。
-
公开(公告)号:US20050019409A1
公开(公告)日:2005-01-27
申请号:US10914486
申请日:2004-08-09
申请人: David Edgren , Francisco Jao , Patrick Wong
发明人: David Edgren , Francisco Jao , Patrick Wong
CPC分类号: A61K9/0065 , Y10S424/06 , Y10S514/836 , Y10S514/866 , Y10S514/884 , Y10S514/909 , Y10S514/96 , Y10S514/961 , Y10S514/965
摘要: The present invention is directed to a multilayered dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent to a fluid environment of use. The active agent dosage form is a multilayer core, often bilayer, formed of polymer matrices that swell upon contact with the fluids of the stomach. At least one layer of the multilayered dosage form includes an active agent. A portion of the polymer matrices are surrounded by a band of insoluble material that prevents the covered portion of the polymer matrices from swelling and provides a segment of the dosage form that is of sufficient rigidity to withstand the contractions of the stomach and delay expulsion of the dosage form from the stomach until substantially all of the active agent has been dispensed.
摘要翻译: 本发明涉及一种多层剂型,其适于保留在胃中并且可用于将活性剂延长递送至使用的流体环境。 活性剂剂型是由与胃液接触时膨胀的聚合物基质形成的多层芯,通常是双层的。 至少一层多层剂型包括活性剂。 聚合物基质的一部分被不溶性材料带包围,其阻止聚合物基质的被覆盖部分膨胀,并且提供具有足够刚度以抵抗胃收缩和延迟排出 剂型,直到基本上所有的活性剂已被分配。
-
3.
公开(公告)号:US06548083B1
公开(公告)日:2003-04-15
申请号:US09615110
申请日:2000-07-13
申请人: Patrick S.-L. Wong , Liang-Chang Dong , David E. Edgren , Felix Theeuwes , Phyllis I. Gardner , Francisco Jao , Jason J. Wan
发明人: Patrick S.-L. Wong , Liang-Chang Dong , David E. Edgren , Felix Theeuwes , Phyllis I. Gardner , Francisco Jao , Jason J. Wan
IPC分类号: A61K922
CPC分类号: A61K9/0065 , A61K9/2072
摘要: The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent formulation to a fluid environment of use. The active agent dosage form is a polymer matrix that swells upon contact with the fluids of the stomach. A portion of the polymer matrix is surrounded by a band of insoluble material that prevents the covered portion of the polymer matrix from swelling and provides a segment of the dosage form that is of sufficient rigidity to withstand the contractions of the stomach and delay expulsion of the dosage form from the stomach until substantially all of the active agent has been dispensed.
摘要翻译: 本发明涉及一种活性剂剂型,其适于保留在胃中并且可用于将活性剂制剂延长递送至使用的流体环境。 活性剂剂型是与胃液接触时膨胀的聚合物基质。 聚合物基质的一部分由不溶性材料带包围,其阻止聚合物基质的被覆盖部分膨胀,并提供具有足够刚性以抵抗胃收缩和延迟排出的部分的剂型 剂型,直到基本上所有的活性剂已被分配。
-
公开(公告)号:US6120803A
公开(公告)日:2000-09-19
申请号:US131923
申请日:1998-08-10
申请人: Patrick S. L. Wong , Liang-Chang Dong , David E. Edgren , Felix Theeuwes , Phyllis I. Gardner , Francisco Jao , Jason J. Wan
发明人: Patrick S. L. Wong , Liang-Chang Dong , David E. Edgren , Felix Theeuwes , Phyllis I. Gardner , Francisco Jao , Jason J. Wan
IPC分类号: A61K47/22 , A61K9/00 , A61K9/20 , A61K9/22 , A61K9/26 , A61K31/341 , A61K31/522 , A61K45/00 , A61P31/12
CPC分类号: A61K9/0065 , A61K9/2072
摘要: The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent formulation to a fluid environment of use. The active agent dosage form is a polymer matrix that swells upon contact with the fluids of the stomach. A portion of the polymer matrix is surrounded by a band of insoluble material that prevents the covered portion of the polymer matrix from swelling and provides a segment of the dosage form that is of sufficient rigidity to withstand the contractions of the stomach and delay expulsion of the dosage form from the stomach until substantially all of the active agent has been dispensed.
-
公开(公告)号:US5674895A
公开(公告)日:1997-10-07
申请号:US445849
申请日:1995-05-22
IPC分类号: A61K9/24 , A61K9/00 , A61K9/20 , A61K31/215 , A61K31/216 , A61K31/221 , A61K47/38 , A61P13/02 , A61P15/00 , A01N37/44 , A61K31/24
CPC分类号: A61K9/2054 , A61K31/216 , A61K31/221 , A61K9/0004 , A61K9/2031
摘要: A composition comprising oxybutynin and a device comprising oxybutynin are disclosed for oxybutynin therapy.
摘要翻译: 公开了包含奥昔布宁的组合物和包含奥昔布宁的装置,用于奥昔布宁治疗。
-
公开(公告)号:US20080021102A1
公开(公告)日:2008-01-24
申请号:US11828028
申请日:2007-07-25
申请人: George Guittard , Francisco Jao , Susan Marks , David Kidney , Fernando Gumucio , Suneel Gupta , Gayatri Sathyan
发明人: George Guittard , Francisco Jao , Susan Marks , David Kidney , Fernando Gumucio , Suneel Gupta , Gayatri Sathyan
CPC分类号: A61K9/209 , A61K9/0004 , A61K9/2031 , A61K9/2054 , A61K31/216 , A61K31/221 , A61K31/24
摘要: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
摘要翻译: 公开了组合物和剂型,其包含单独的奥昔布宁或伴随着另一种用于治疗的药物。 公开了用于单独/或伴随不同药物的奥昔布宁或根据用于单独治疗失禁的治疗程序以及用于其它治疗的奥昔布宁和不同药物施用奥昔布宁的方法。
-
公开(公告)号:US06797283B1
公开(公告)日:2004-09-28
申请号:US09469399
申请日:1999-12-22
IPC分类号: A61K924
CPC分类号: A61K9/0065 , Y10S424/06 , Y10S514/836 , Y10S514/866 , Y10S514/884 , Y10S514/909 , Y10S514/96 , Y10S514/961 , Y10S514/965
摘要: The present invention is directed to a multilayered dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent to a fluid environment of use. The active agent dosage form is a multilayer core, often bilayer, formed of polymer matrices that swell upon contact with the fluids of the stomach. At least one layer of the multilayered dosage form includes an active agent. A portion of the polymer matrices are surrounded by a band of insoluble material that prevents the covered portion of the polymer matrices from swelling and provides a segment of the dosage form that is of sufficient rigidity to withstand the contractions of the stomach and delay expulsion of the dosage form from the stomach until substantially all of the active agent has been dispensed.
摘要翻译: 本发明涉及一种多层剂型,其适于保留在胃中并且可用于将活性剂延长递送至使用的流体环境。 活性剂剂型是由与胃液接触时膨胀的聚合物基质形成的多层芯,通常是双层的。 至少一层多层剂型包括活性剂。 聚合物基质的一部分被不溶性材料带包围,其阻止聚合物基质的被覆盖部分膨胀,并且提供具有足够刚度以抵抗胃收缩和延迟排出 剂型,直到基本上所有的活性剂已被分配。
-
公开(公告)号:US06262115B1
公开(公告)日:2001-07-17
申请号:US09280309
申请日:1999-03-29
IPC分类号: A01N3744
CPC分类号: A61K9/209 , A61K9/0004 , A61K9/2031 , A61K9/2054 , A61K31/216 , A61K31/221 , A61K31/24
摘要: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
摘要翻译: 公开了组合物和剂型,其包含单独的奥昔布宁或伴随着另一种用于治疗的药物。 公开了用于单独/或伴随不同药物的奥昔布宁或根据用于单独治疗失禁的治疗程序以及用于其它治疗的奥昔布宁和不同药物施用奥昔布宁的方法。
-
公开(公告)号:US06365183B1
公开(公告)日:2002-04-02
申请号:US09274648
申请日:1999-03-23
IPC分类号: A61K922
CPC分类号: A61K9/2072 , A61K9/2095 , A61K9/2893
摘要: The present invention is directed to an active agent dosage form and methods of its fabrication which is useful for the prolonged delivery of an active agent formulation to a fluid environment of use. The active agent dosage form is a matrix that has on its surface one or more insoluble bands located in complementary grooves. The invention is also directed to articles of manufacture, methods and systems for fabricating the active agent dosage form.
-
公开(公告)号:US6124355A
公开(公告)日:2000-09-26
申请号:US78192
申请日:1998-05-13
IPC分类号: A61K9/00 , A61K9/20 , A61K31/216 , A61K31/221 , A01N37/44
CPC分类号: A61K9/0004 , A61K31/216 , A61K31/221 , A61K9/2031 , A61K9/2054
摘要: A composition comprising oxybutynin, a dosage form comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
摘要翻译: 公开了包含奥昔布宁的组合物,包含奥昔布宁的剂型和用于奥昔布宁治疗的奥昔布宁的施用方法。
-
-
-
-
-
-
-
-
-